OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A phase I, randomized, ascending‐dose study to assess safety, pharmacokinetics, and activity of GDC‐8264, a RIP1 inhibitor, in healthy volunteers
Nicholas S. Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1997-2009
Open Access | Times Cited: 8
Nicholas S. Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1997-2009
Open Access | Times Cited: 8
Showing 8 citing articles:
Acute lung injury: a view from the perspective of necroptosis
Jinyan Dong, Weihong Liu, Wenli Liu, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 997-1018
Closed Access | Times Cited: 6
Jinyan Dong, Weihong Liu, Wenli Liu, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 997-1018
Closed Access | Times Cited: 6
The Role of Necroptosis in Pathological Pregnancies: Mechanisms and Therapeutic Opportunities
Lidan He, Shan Zheng, Feng Zhan, et al.
Journal of Reproductive Immunology (2025) Vol. 169, pp. 104460-104460
Closed Access
Lidan He, Shan Zheng, Feng Zhan, et al.
Journal of Reproductive Immunology (2025) Vol. 169, pp. 104460-104460
Closed Access
Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy
Asim Kumar Bepari, Swakkhar Shatabda, Hasan Mahmud Reza
PeerJ (2024) Vol. 12, pp. e16762-e16762
Open Access | Times Cited: 3
Asim Kumar Bepari, Swakkhar Shatabda, Hasan Mahmud Reza
PeerJ (2024) Vol. 12, pp. e16762-e16762
Open Access | Times Cited: 3
Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives
Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 2, pp. 32-32
Open Access | Times Cited: 3
Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 2, pp. 32-32
Open Access | Times Cited: 3
Regulation of RIPK1 Phosphorylation: Implications for Inflammation, Cell Death, and Therapeutic Interventions
Jingchun Du, Zhigao Wang
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1525-1525
Open Access | Times Cited: 3
Jingchun Du, Zhigao Wang
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1525-1525
Open Access | Times Cited: 3
Biomaterials Functionalized with Inflammasome Inhibitors - Premises and Perspectives
Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, et al.
(2024)
Open Access | Times Cited: 1
Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, et al.
(2024)
Open Access | Times Cited: 1
A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants
Ana Liza Andresan Sun, John Gillies, Yang Shen, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 1
Ana Liza Andresan Sun, John Gillies, Yang Shen, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 1
